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Splicing takes a NAP
 
plicing factors, usually associated
with RNA polymerase II transcripts,
have a temporary home near sites of
RNA polymerase I transcription, as shown on
page 51 by Bubulya et al.
During interphase, premRNA splicing
factors such as the serine arginine–rich (SR)
proteins reside in nuclear speckles, along with
other pre-mRNA processing proteins. The
speckles disassemble during mitosis, and then
reform in G1. By viewing speckle reformation,
the group finds that SR proteins first make a
side trip and gather in nucleolar organizing
region–associated patches (NAPs), around
areas where rDNA is transcribed.
Inhibiting mRNA transcription prolonged
the life of NAPs and also caused SR proteins to
accumulate near nucleoli in interphase cells.
Without their pre-mRNA transcript targets avail-
able, SR protein traffic was backed up at a lo-
cation it would otherwise move through rapidly.
NAPs contained hypophosphorylated
SR proteins, which may self-associate and
thus accumulate in patches. NAPs also con-
tained an SR protein kinase, whose activity
may release the splicing factors to transcrip-
tion sites, although it is not clear how active
RNA polymerase II might signal to effect such
a change. At NAPs, the SR proteins are se-
questered from other splicing factors. Their
isolation during telophase may be needed for
modification or SR complex assembly in re-
forming daughter nuclei. Why SR proteins
choose NAPs for their meeting point remains
to be determined. 
S
Splicing factors (green) are found around rDNA 
transcription sites (red).
 
Talin for presynaptic 
endocytosis
 
alin links integrins to the actin cytoskeleton at focal adhesions. On
page 43, Morgan et al. show that talin also links synaptic activity
to actin rearrangements.
Synapses are specialized sites of cell adhesion that were recently
shown to hold talin. Talin interacts with PIPKI
 
 
 
, a PI(4,5)P
 
2
 
-producing
enzyme, which in turn regulates talin and other actin regulatory proteins.
The importance of this interaction is now shown at synapses, where
PI(4,5)P
 
2
 
 also controls clathrin coat dynamics.
The authors inter-
fered with talin–PIPKI
 
 
 
interactions in the ax-
ons of giant lamprey
neurons. The interfer-
ence  inhibited the re-
cycling of synaptic
vesicles on the pre-
synaptic side. Clathrin-
coated pits formed but did not bud off the plasma membrane. These
changes were associated with reduced synaptic actin networks. The de-
fects are probably due to low levels of PI(4,5)P
 
2
 
 resulting from a block in
PIPKI
 
 
 
 recruitment to the membrane. The same lab has also recently shown
genetically that PI(4,5)P
 
2
 
 is necessary for synaptic vesicle trafficking (Di Pa-
olo et al. 
 
Nature
 
. 431:415–422).
As PIP
 
2
 
 production is up-regulated by neuronal depolarization, the
authors are now studying how the talin-PIPKI
 
 
 
 interaction is affected by the
firing of synapses. 
T
Rings of actin (green) around synaptic vesicle clus-
ters are lost when talin cannot bind PIPKI  (right).
 
Export in cystic ﬁbrosis
 
ystic fibrosis (CF) often results from the failure of the CFTR chloride
channel to hook up with the COPII machinery, based on results
from Wang et al. (page 65).
The most common form of CF occurs in response to loss of phen-
ylalanine 508 (F508) in CFTR, resulting in a failure to be exported from
the ER. F508 deletion leads to protein misfolding and ER-associated deg-
radation (ERAD). Many groups thus hope to interfere with ERAD to treat
CF. But Wang et al. find that the solution may lie elsewhere. “We don’t
think less degradation,” says group leader William Balch. “We think
more export.”
Export to the Golgi is required for CFTR to get to its functional location
on the cell surface. The authors find that this export relies on a conserved
di-acidic motif that must be properly presented to Sec24, a component of
the COPII coat.
CFTR with mutations in the di-acidic motif were not exported and were
less likely to associate with Sec24 in vivo. Recent crystal structures show that
F508 lies in a domain adjacent to the di-acidic motif; the loss of F508 and the
resulting misfolding may thus hide the sorting motif from Sec24.
Promising small molecule drug candidates for CF might be selected by
their ability to improve interactions between Sec24 and the CFTR domain
that contains the di-acidic motif. Blocking ERAD, in contrast, may only lead
to ER-trapped CFTR, which could trigger ER stress responses. 
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